PHGE

BiomX (PHGE)

About BiomX (PHGE)

BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Gaithersburg, MD.

Details

Daily high
$0.98
Daily low
$0.91
Price at open
$0.92
52 Week High
$8.55
52 Week Low
$0.88
Market cap
6.4M
Dividend yield
0.00%
Volume
29,525
Avg. volume
48,389
P/E ratio
-.15

BiomX News

Details

Daily high
$0.98
Daily low
$0.91
Price at open
$0.92
52 Week High
$8.55
52 Week Low
$0.88
Market cap
6.4M
Dividend yield
0.00%
Volume
29,525
Avg. volume
48,389
P/E ratio
-.15